Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Campone

Showing results (101-110 of 302) with videos related to

Pageof 31
Sort By:
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 6, 2020
Combining Superpixels and Deep Learning Approaches to Segment Active Organs in Metastatic Breast Cancer PET Images<sup>.</sup>Constance Fourcade, Ludovic Ferrer, Gianmarco Santini, et al.
Breast Cancer Research and Treatment|October 25, 2017
Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significanceJérôme Abadie, Frédérique Nguyen, Delphine Loussouarn, et al.
Breast Cancer Research and Treatment|April 15, 2018
Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2Sunil Verma, Joyce O'Shaughnessy, Howard A Burris, et al.
Critical Reviews in Oncology/Hematology|December 17, 2008
Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysisMichèle Tubiana-Hulin, Marc Spielmann, Christian Roux, et al.
Cancer Treatment and Research Communications|January 7, 2026
Favourable long-term outcomes in selected HER2-Positive early breast cancer patients without pathological complete response after neoadjuvant chemotherapy and trastuzumab: A pre-T-DM1 era cohort studyLudovic Doucet, Camille Moreau-Bachelard, Laurent Mathiot, et al.
Cancer Chemotherapy and Pharmacology|October 24, 2018
Phase I trial of afatinib and 3-weekly trastuzumab with optimal anti-diarrheal management in patients with HER2-positive metastatic cancerNicolas Martin, Nicolas Isambert, Carlos Gomez-Roca, et al.
Breast Cancer Research : BCR|April 19, 2015
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune responsePascal Jézéquel, Delphine Loussouarn, Catherine Guérin-Charbonnel, et al.
Breast Cancer Research and Treatment|July 31, 2007
Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimenMario Campone, Loïc Campion, Henry Roché, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2011
A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancerErica L Mayer, Jean-Francois Baurain, Joseph Sparano, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2012
Folate supplementation limits the tumourigenesis in rodent models of gliomagenesisPierre-François Cartron, Eric Hervouet, Emilie Debien, et al.
Pageof 31

Showing results (101-110 of 302) with videos related to

Sort By:
Pageof 31
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 6, 2020
Combining Superpixels and Deep Learning Approaches to Segment Active Organs in Metastatic Breast Cancer PET Images<sup>.</sup>Constance Fourcade, Ludovic Ferrer, Gianmarco Santini, et al.
Breast Cancer Research and Treatment|October 25, 2017
Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significanceJérôme Abadie, Frédérique Nguyen, Delphine Loussouarn, et al.
Breast Cancer Research and Treatment|April 15, 2018
Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2Sunil Verma, Joyce O'Shaughnessy, Howard A Burris, et al.
Critical Reviews in Oncology/Hematology|December 17, 2008
Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysisMichèle Tubiana-Hulin, Marc Spielmann, Christian Roux, et al.
Cancer Treatment and Research Communications|January 7, 2026
Favourable long-term outcomes in selected HER2-Positive early breast cancer patients without pathological complete response after neoadjuvant chemotherapy and trastuzumab: A pre-T-DM1 era cohort studyLudovic Doucet, Camille Moreau-Bachelard, Laurent Mathiot, et al.
Cancer Chemotherapy and Pharmacology|October 24, 2018
Phase I trial of afatinib and 3-weekly trastuzumab with optimal anti-diarrheal management in patients with HER2-positive metastatic cancerNicolas Martin, Nicolas Isambert, Carlos Gomez-Roca, et al.
Breast Cancer Research : BCR|April 19, 2015
Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune responsePascal Jézéquel, Delphine Loussouarn, Catherine Guérin-Charbonnel, et al.
Breast Cancer Research and Treatment|July 31, 2007
Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimenMario Campone, Loïc Campion, Henry Roché, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2011
A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancerErica L Mayer, Jean-Francois Baurain, Joseph Sparano, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2012
Folate supplementation limits the tumourigenesis in rodent models of gliomagenesisPierre-François Cartron, Eric Hervouet, Emilie Debien, et al.
Pageof 31